Adial Pharmaceuticals Inc (ADIL)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | YOUNG, WENDY B. | Director | Stock Option (Right to Buy) | Acquisition | 25,666 | 0 |
| Jul 16, 2026 | COASTLANDS, CAPITAL LP | 10% Owner | Common Stock | Acquisition | 1,233 | 2.75 |
| Jul 14, 2026 | COASTLANDS, CAPITAL LP | 10% Owner | Common Stock | Acquisition | 2,000 | 2.65 |
| Jul 10, 2026 | COASTLANDS, CAPITAL LP | 10% Owner | Common Stock | Acquisition | 1,700 | 2.7 |
| Jul 9, 2026 | COASTLANDS, CAPITAL LP | 10% Owner | Common Stock | Acquisition | 10,053 | 2.79 |
| Jun 29, 2026 | COASTLANDS, CAPITAL LP | 10% Owner | Common Stock | Acquisition | 25,000 | 2.6 |
| Jun 12, 2026 | YOUNG, WENDY B. | Director | Pre-funded Warrant | Acquisition | 36,378 | 2.749 |
| Jun 12, 2026 | DAVIDSON, MATT | Director, Chief Development Officer | Common Stock | Acquisition | 232,417 | 0 |
| Jun 12, 2026 | DAVIDSON, MATT | Director, Chief Development Officer | Stock Option (Right to Buy) | Acquisition | 232,417 | 0 |
| Jun 11, 2026 | DAVIDSON, MATT | Director, Chief Development Officer | Series A Preferred Stock | Acquisition | 101.298 | |
| Jun 11, 2026 | DAVIDSON, MATT | Director, Chief Development Officer | Common Stock | Acquisition | 61,647 | |
| Jun 11, 2026 | DAVIDSON, MATT | Director, Chief Development Officer | Series A Preferred Stock | Acquisition | 1,822.13 | |
| Jun 11, 2026 | DAVIDSON, MATT | Director, Chief Development Officer | Common Stock | Acquisition | 3,427 | |
| Apr 7, 2026 | SHAH, VINAY | Chief Financial Officer | Common Stock | Acquisition | 17,325 | 0 |
| Apr 7, 2026 | ANDERSON, J. KERMIT | Director | Stock Option (Right to Buy) | Acquisition | 9,185 | 0 |
| Apr 7, 2026 | GILLILAND, ROBERTSON H. | Director | Common Stock | Acquisition | 9,185 | 0 |
| Apr 7, 2026 | SCHUYLER, KEVIN | Director | Common Stock | Acquisition | 9,185 | 0 |
| Apr 7, 2026 | CLAIBORNE, CARY J | Director, Chief Executive Officer | Common Stock | Acquisition | 37,985 | 0 |
| Apr 7, 2026 | GOODMAN, TONY | Director, Chief Operating Officer | Common Stock | Acquisition | 26,510 | 0 |